Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

休市中 01-09 16:00:00 EST

112.92

-1.23

-1.08%

盘后112.87

-0.05-0.04%

19:53 EST

最高114.77	最低110.71	成交量57.56万
今开113.90	昨收114.15	日振幅3.56%
总市值64.86亿	流通市值62.56亿	总股本5,743万
成交额6,479万	换手率1.04%	流通股本5,540万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":112.92,"timestamp":1767992400000,"preClose":114.15,"halted":0,"volume":575642,"hourTrading":{"tag":"盘后","latestPrice":112.87,"preClose":112.92,"latestTime":"19:53 EST","volume":12117,"amount":1368236.64,"timestamp":1768006427998},"delay":0,"floatShares":55401390,"shares":57434740,"eps":-1.544832,"marketStatus":"休市中","change":-1.23,"latestTime":"01-09 16:00:00 EST","open":113.9,"high":114.77,"low":110.71,"amount":64789395.891248,"amplitude":0.035567,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.544832,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NYSE","adjPreClose":114.15,"postHourTrading":{"tag":"盘后","latestPrice":112.87,"preClose":112.92,"latestTime":"19:53 EST","volume":12117,"amount":1368236.64,"timestamp":1768006427998},"volumeRatio":1.0519119691916068,"impliedVol":0.5715,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/GKOS","defaultTab":"news","newsList":[{"id":"1157275147","title":"异动解读 | 业绩超预期，Glaukos盘前大涨20.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157275147","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157275147?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:44","pubTimestamp":1761824664,"startTime":"0","endTime":"0","summary":"眼科医疗技术公司Glaukos Corp周四盘前股价大涨20.90%，引发投资者广泛关注。根据公司公布的财报，Glaukos第三季度销售额达到1.335亿美元，远超市场分析机构IBES预期的1.225亿美元。Glaukos的这份优异财报显示，公司在眼科医疗技术领域的市场地位不断巩固，产品需求旺盛。高于预期的销售额和毛利率大大提振了投资者信心，推动股价在盘前交易中大幅上涨。这一业绩表现也凸显了Glaukos在眼科医疗技术市场的竞争力和增长潜力，有望为公司未来的持续发展奠定坚实基础。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1125583389","title":"异动解读 | 业绩超预期，Glaukos夜盘大涨18.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125583389","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125583389?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:41","pubTimestamp":1761784860,"startTime":"0","endTime":"0","summary":"眼科医疗技术公司Glaukos Corp周三夜盘交易中股价大幅上涨18.23%，引发投资者广泛关注。这一显著涨幅主要源于公司发布的亮眼第三季度财报。根据公司公布的财报，Glaukos第三季度销售额达到1.335亿美元，远超市场分析机构IBES预期的1.225亿美元。Glaukos的这份优异财报显示，公司在眼科医疗技术领域的市场地位不断巩固，产品需求旺盛。这一业绩表现也凸显了Glaukos在眼科医疗技术市场的竞争力和增长潜力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1139565949","title":"异动解读 | 业绩超预期，Glaukos盘后大涨14.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139565949","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139565949?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:33","pubTimestamp":1761769981,"startTime":"0","endTime":"0","summary":"周三盘后交易中，眼科医疗技术公司Glaukos Corp股价大幅上涨14.15%，引发投资者广泛关注。Glaukos公布的第三季度销售额达到1.335亿美元，远超市场分析机构IBES预期的1.225亿美元。此外，公司第三季度调整后毛利率高达84%，展现出强劲的盈利能力。Glaukos的这份优异财报显示，公司在眼科医疗技术领域的市场地位不断巩固，产品需求旺盛。高于预期的销售额和毛利率不仅反映了公司的业务增长势头，也表明其在成本控制和运营效率方面取得了显著进展。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1153490464","title":"Glaukos第三季度销售额1.335亿美元，超出IBES预期的1.225亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153490464","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153490464?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:25","pubTimestamp":1761769527,"startTime":"0","endTime":"0","summary":"10月29日 - Glaukos第三季度调整后毛利率达到84%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4548","BK4082","LU2065731478.USD","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"1139866422","title":"Glaukos Corp：富国银行将评级从持平上调至增持；目标价由92美元上调至120美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139866422","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139866422?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:02","pubTimestamp":1761562948,"startTime":"0","endTime":"0","summary":"Glaukos Corp：富国银行将评级从持平上调至增持；目标价由92美元上调至120美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","LU2065731478.USD","GKOS","BK4548","LU1878469433.USD","BK4082"],"gpt_icon":0},{"id":"2567189245","title":"Glaukos Corporation盘中异动 急速跳水5.09%报83.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567189245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567189245?lang=zh_cn&edition=full","pubTime":"2025-09-13 00:42","pubTimestamp":1757695345,"startTime":"0","endTime":"0","summary":"北京时间2025年09月13日00时42分，Glaukos Corporation股票出现异动，股价快速跳水5.09%。截至发稿，该股报83.02美元/股，成交量22.8241万股，换手率0.40%，振幅4.97%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.76%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913004225a4c31225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913004225a4c31225&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4548","LU1878469433.USD","BK4082","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"2556784808","title":"Glaukos Corporation2025财年第二财季实现净利润-19.66百万美元，同比增加61.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556784808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556784808?lang=zh_cn&edition=full","pubTime":"2025-08-04 00:01","pubTimestamp":1754236867,"startTime":"0","endTime":"0","summary":"8月4日，Glaukos Corporation公布财报，公告显示公司2025财年第二财季净利润为-19.66百万美元，同比增加61.11%；其中营业收入为1.24亿美元，同比增加29.59%，每股基本收益为-0.34美元。从资产负债表来看，Glaukos Corporation总负债2.22亿美元，其中短期债务--，资产负债比为4.45，流动比率为0.06。机构评级：截至2025年8月4日，当前有13家机构对Glaukos Corporation目标价做出预测，其中目标均价为122.46美元，其中最低目标价为72.00美元，最高目标价为165.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804000231a472bcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804000231a472bcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"1176545036","title":"异动解读 | 眼科医疗公司Glaukos股价盘中大跌5.03%，多家券商调整目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1176545036","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176545036?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:51","pubTimestamp":1753969886,"startTime":"0","endTime":"0","summary":"周四盘中，眼科医疗设备公司Glaukos Corp股价出现大幅下跌，截至盘中跌幅达5.03%。造成Glaukos股价下跌的原因可能与多家知名投资银行对该公司的最新评级调整有关。此外，瑞穗证券也将Glaukos的目标价从150美元下调至130美元，富国银行则将目标价从86美元上调至92美元。这些不同方向的目标价调整反映了分析师对Glaukos未来前景看法的分歧。市场将继续关注Glaukos的后续表现，以及公司能否通过强劲的业绩来重新赢得投资者的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2551126348","title":"Glaukos Corporation涨1.78% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126348?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:03","pubTimestamp":1752674586,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时03分，Glaukos Corporation股票出现异动，股价急速拉升1.78%。截至发稿，该股报100.01美元/股，成交量4.41万股，换手率0.08%，振幅1.42%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.09%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716220307a6adaefc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716220307a6adaefc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","IE0009354923.USD","BK4082","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2551198155","title":"Glaukos Corporation跌4.50% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551198155?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:39","pubTimestamp":1752586783,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时39分，Glaukos Corporation股票出现波动，股价快速跳水4.50%。截至发稿，该股报99.50美元/股，成交量2.6731万股，换手率0.05%，振幅2.78%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.13%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521394395438ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521394395438ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","GKOS","BK4082","BK4548","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2518322289","title":"Glaukos Corporation跌4.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518322289?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613579,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Glaukos Corporation股票出现波动，股价急速跳水4.08%。截至发稿，该股报99.94美元/股，成交量8598股，换手率0.02%，振幅1.40%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.62%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","LU1878469433.USD","BK4548","LU2065731478.USD","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"2517319455","title":"Glaukos Corporation盘中异动 下午盘急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517319455?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:26","pubTimestamp":1741285610,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时26分，Glaukos Corporation股票出现波动，股价快速跳水5.14%。截至发稿，该股报106.36美元/股，成交量29.6086万股，换手率0.52%，振幅3.26%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为2.00%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","LU1878469433.USD","BK4082","LU2065731478.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2516373576","title":"Glaukos Corporation盘中异动 早盘急速下跌5.18%报113.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516373576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516373576?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014342,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Glaukos Corporation股票出现波动，股价大幅下挫5.18%。截至发稿，该股报113.80美元/股，成交量10.7329万股，换手率0.19%，振幅4.82%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.59%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","IE0009354923.USD","LU1878469433.USD","GKOS","BK4082","BK4548"],"gpt_icon":0},{"id":"2514015888","title":"Glaukos Corporation盘中异动 早盘股价大跌5.20%报117.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015888?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:11","pubTimestamp":1740496279,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时11分，Glaukos Corporation股票出现异动，股价急速下跌5.20%。截至发稿，该股报117.78美元/股，成交量19.1002万股，换手率0.34%，振幅5.88%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.41%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","IE0009354923.USD","BK4082","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2513375613","title":"Glaukos Corporation2024财年实现净利润-1.46亿美元，同比减少8.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513375613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513375613?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326467,"startTime":"0","endTime":"0","summary":"2月24日，Glaukos Corporation公布财报，公告显示公司2024财年净利润为-1.46亿美元，同比减少8.15%；其中营业收入为3.83亿美元，同比增加21.59%，每股基本收益为-2.77美元。从资产负债表来看，Glaukos Corporation总负债2.08亿美元，其中短期债务--，资产负债比为4.69，流动比率为0.06。机构评级：截至2025年2月24日，当前有13家机构对Glaukos Corporation目标价做出预测，其中目标均价为168.62美元，其中最低目标价为120.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"1174826046","title":"异动解读 | 医疗器械公司Glaukos第四季度亏损扩大 股价大跌13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174826046","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174826046?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:37","pubTimestamp":1740148650,"startTime":"0","endTime":"0","summary":"医疗技术公司Glaukos(GKOS)今日盘中大跌13.2%,引发市场广泛关注。\n\n该公司昨日公布了2024年第四季度财报,数据显示当季净亏损达到2220万美元,大幅超出市场预期的2080万美元亏损。尽管营收达到1.055亿美元高于预期,但亏损扩大的情况仍令投资者信心受挫。\n\n值得一提的是,Glaukos的主要产品iStent inject W是一种用于治疗青光眼的创新医疗器械,针对这种常见但损害视神经的眼病。公司的这一核心业务前景广阔,但本季度的财报业绩不佳或许给市场带来一些负面影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2513296561","title":"Glaukos Corporation盘中异动 急速下挫12.32%报137.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296561?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:32","pubTimestamp":1740148334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时32分，Glaukos Corporation股票出现波动，股价快速下挫12.32%。截至发稿，该股报137.97美元/股，成交量13.5999万股，换手率0.24%，振幅3.79%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.36%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223214abd7afc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223214abd7afc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4082","LU1878469433.USD","LU2065731478.USD","IE0009354923.USD","GKOS"],"gpt_icon":0},{"id":"1126707519","title":"异动解读 | 医疗技术公司Glaukos第四季度亏损扩大,股价盘前大跌11.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126707519","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126707519?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:10","pubTimestamp":1740147030,"startTime":"0","endTime":"0","summary":"医疗技术公司Glaukos(GKOS)股价今日盘前大跌11.67%,引发市场广泛关注。\n\nGlaukos公司昨日发布了第四季度财报,数据显示该公司第四季度净亏损扩大至2220万美元,远超市场预期的2080万美元亏损。虽然营收达到1.055亿美元高于市场预期,但仍未能令投资者信心完全恢复。\n\n值得一提的是,Glaukos的主要产品iStent inject W是一种用于治疗青光眼的创新医疗器械,针对一种损害视神经的严重眼病。公司业务发展前景一直备受市场关注,但近期财务数据不佳或许给投资者带来一些负面影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2513267826","title":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由149.00美元调整至176.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513267826","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513267826?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:51","pubTimestamp":1740142319,"startTime":"0","endTime":"0","summary":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由149.00美元调整至176.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21205148319260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1151662734","title":"异动解读 | GKOS公司盘后大跌14.21%,财报亏损超预期或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1151662734","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151662734?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:32","pubTimestamp":1740087147,"startTime":"0","endTime":"0","summary":"眼科医疗器械公司GKOS(Glaukos Corp)股价于今日盘后大跌14.21%,引发市场广泛关注。\n\n分析认为,公司2024年第四季度财报表现可能是股价大跌的主要诱因。数据显示,GKOS上季度销售额达到1.055亿美元,同比增长28.09%,超出分析师预期。但公司每股亏损达到0.40美元,高于预期的0.38美元,这可能令投资者对公司增长前景产生担忧,加大抛售力度。\n\n不过,仅从财报数据看,14.21%的大跌幅度似乎过大,分析人士推测可能还存在其他市场暂未掌握的负面消息,共同导致股价重挫。GKOS当前盈利能力不济的状态是否将持续,以及公司未来能否重现增长,仍需进一步观察。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | GKOS公司盘后大跌14.21%,财报亏损超预期或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.3677},{"period":"6month","weight":0.0878},{"period":"1year","weight":-0.2859},{"period":"ytd","weight":0.0001}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司，专注于开发新型无滴剂疗法，并将相关产品商业化，用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术（MIGS）作为传统青光眼治疗模式的替代方案，并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法，用于治疗罕见的角膜疾病圆锥角膜，该疗法于2016年获得美国食品和药物管理局（FDA）的批准。他们正在开发一系列平台，以支持正在进行的制药和医疗器械创新。","yearOnYearQuotes":[{"month":1,"riseRate":0.909091,"avgChangeRate":0.078539},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00698},{"month":3,"riseRate":0.6,"avgChangeRate":-0.022683},{"month":4,"riseRate":0.5,"avgChangeRate":0.010953},{"month":5,"riseRate":0.6,"avgChangeRate":0.024636},{"month":6,"riseRate":0.9,"avgChangeRate":0.110675},{"month":7,"riseRate":0.636364,"avgChangeRate":0.018448},{"month":8,"riseRate":0.454545,"avgChangeRate":0.049318},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.031897},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.015452},{"month":11,"riseRate":0.545455,"avgChangeRate":0.030479},{"month":12,"riseRate":0.545455,"avgChangeRate":0.013516}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}